PAX5 and leukemia: Hence, deregulated PAX5 expression has major implications in physiologic hematopoiesis and poses a high risk for leukemia development, with somatic alterations being one of the most common features present in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) [12].